| Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial J He, R Zhang, M Shao, X Zhao, M Miao, J Chen, J Liu, X Zhang, X Zhang, ... Annals of the rheumatic diseases 79 (1), 141-149, 2020 | 294 | 2020 |
| CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21 H Chen, C Li, J Huang, T Cung, K Seiss, J Beamon, MF Carrington, ... The Journal of clinical investigation 121 (4), 1549-1560, 2011 | 210 | 2011 |
| APLAR rheumatoid arthritis treatment recommendations CS Lau, F Chia, A Harrison, TY Hsieh, R Jain, SM Jung, M Kishimoto, ... International journal of rheumatic diseases 18 (7), 685-713, 2015 | 154 | 2015 |
| Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China AC Liu, Y Yang, MT Li, Y Jia, S Chen, S Ye, XZ Zeng, Z Wang, JX Zhao, ... Clinical rheumatology 37, 93-100, 2018 | 83 | 2018 |
| Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2 J Huang, P Burke, Y Yang, K Seiss, J Beamon, T Cung, I Toth, F Pereyra, ... Journal of virology 84 (20), 10784-10791, 2010 | 69 | 2010 |
| Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled … X Zhang, M Miao, R Zhang, X Liu, X Zhao, M Shao, T Liu, Y Jin, J Chen, ... Signal Transduction and Targeted Therapy 7 (1), 67, 2022 | 49 | 2022 |
| Contribution of Functional LILRA3, but Not Nonfunctional LILRA3, to Sex Bias in Susceptibility and Severity of Anti–Citrullinated Protein Antibody–Positive … Y Du, Y Cui, X Liu, F Hu, Y Yang, X Wu, X Liu, X Ma, X Zuo, Y Sheng, ... Arthritis & rheumatology 66 (4), 822-830, 2014 | 48 | 2014 |
| Dendritic cell dysfunction during primary HIV-1 infection J Huang, Y Yang, M Al-Mozaini, PS Burke, J Beamon, MF Carrington, ... Journal of Infectious Diseases 204 (10), 1557-1562, 2011 | 46 | 2011 |
| Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome Y Du, Y Su, J He, Y Yang, Y Shi, Y Cui, C Luo, X Wu, X Liu, F Hu, X Ma, ... Annals of the Rheumatic Diseases 74 (11), 2070-2075, 2015 | 44 | 2015 |
| CD4 T-cell regeneration in HIV-1 elite controllers Y Yang, M Al-Mozaini, MJ Buzon, J Beamon, S Ferrando-Martinez, ... Aids 26 (6), 701-706, 2012 | 41 | 2012 |
| Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population J Guo, T Zhang, H Cao, X Li, H Liang, M Liu, Y Zou, Y Zhang, Y Wang, ... Annals of the rheumatic diseases 78 (6), 773-780, 2019 | 35 | 2019 |
| Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study. Z Li, J Hu, C Bao, X Li, J Xu, AJ Spindler, X Zhang, D He, G Wang, Y Yang, ... Clinical and Experimental Rheumatology 38 (4), 732-741, 2020 | 33 | 2020 |
| Interleukin-2 deficiency associated with renal impairment in systemic lupus erythematosus M Shao, J He, R Zhang, X Zhang, Y Yang, C Li, X Liu, X Sun, Z Li Journal of Interferon & Cytokine Research 39 (2), 117-124, 2019 | 32 | 2019 |
| Susceptibility to CD8 T-Cell–Mediated Killing Influences the Reservoir of Latently HIV-1–Infected CD4 T Cells MJ Buzon, Y Yang, Z Ouyang, H Sun, K Seiss, J Rogich, S Le Gall, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 65 (1), 1-9, 2014 | 28 | 2014 |
| Monoclonal gammopathy in rheumatic diseases Y Yang, L Chen, Y Jia, Y Liu, L Wen, Y Liang, Y An, S Chen, Y Su, Z Li Clinical Rheumatology 37, 1751-1762, 2018 | 26 | 2018 |
| Efficacy and safety of baricitinib in Chinese rheumatoid arthritis patients and the subgroup analyses: results from study RA-BALANCE Y Yang, XF Li, X Zhang, CD Bao, JK Hu, JH Xu, XP Li, J Xu, DY He, ZJ Li, ... Rheumatology and therapy 7, 851-866, 2020 | 21 | 2020 |
| Autoimmune diseases in China R Li, X Sun, X Liu, Y Yang, Z Li Advances in immunology 144, 173-216, 2019 | 20 | 2019 |
| Serum soluble CD25 as a risk factor of renal impairment in systemic lupus erythematosus—a prospective cohort study RJ Zhang, X Zhang, J Chen, M Shao, Y Yang, B Balaubramaniam, ... Lupus 27 (7), 1100-1106, 2018 | 18 | 2018 |
| The COVID-19 vaccine: Attitudes and vaccination in patients with autoimmune inflammatory rheumatic diseases J Chen, W Cai, T Liu, Y Zhou, Y Jin, Y Yang, S Chen, K Tang, C Li Rheumatology & Autoimmunity 2 (02), 82-91, 2022 | 14 | 2022 |
| Investigation of C1-complex regions reveals new C1Q variants associated with protection from systemic lupus erythematosus, and affect its transcript abundance J Guo, Y Gao, Y Wang, Y Zou, Y Du, C Luo, Y Shi, Y Yang, X Wu, Y Su, ... Scientific Reports 8 (1), 8048, 2018 | 14 | 2018 |
